Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
5(100.0%)
5Total
N/A(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT04820322Not ApplicableCompleted

Comparison of the Postprandial Glycemic and Insulinemic Response After a Fibersym Containing Cookie With a Control

Role: lead

NCT04277741Not ApplicableWithdrawn

Long-term Consumption of Resistant Starch Type-4 (RS4)

Role: collaborator

NCT00691249Not ApplicableCompleted

Resistant Starch on Glucose and Insulin Sensitivity in Individuals With Type 2 Diabetes

Role: collaborator

NCT00687960Not ApplicableCompleted

Effect of Resistant Starch Type 4 on Glycemia and Insulin Sensitivity in Young Adults

Role: collaborator

NCT00676767Not ApplicableCompleted

Resistant Starch on Glycemic Response in Older Adults

Role: collaborator

All 5 trials loaded